Perform routine, high-throughput, non-GLP sample analysis using established ligand-binding assays (ELISA, hybridization ELISA, MSD, Quanterix, and ELLA) and immunoassays (Western blot and Jess) to support pharmacokinetic (PK), target engagement, and pharmacodynamic (PD) assessments across a variety of biological matrices. This individual will focus on high-quality sample analysis using established methods, generating reliable data to inform drug exposure, target engagement, pharmacodynamic (PD) responses, and biomarker endpoints across preclinical species and biological matrices, supporting the advancement of RNAi therapeutics.